CorMedix Inc. - Special Call Transcript
Greetings, and welcome to antimicrobial resistance, catheter-related blood stream infections and the potential for Neutrolin, hosted by CorMedix conference call. (Operator Instructions) As a reminder, this conference is being recorded.
I would now like to turn the conference over to your host, Dr. Paul Chew, Chief Medical Officer from CorMedix. Mr. Chew, you may begin.
Good morning, and good afternoon, everyone. Welcome to the CorMedix webinar antimicrobial resistance, catheter-related bloodstream infections and the potential for Neutrolin. Please read the forward-looking statement slide when you have a chance.
COVID-19 is a global pandemic that's focusing everyone on the need for disease prevention, but there's a group, a vulnerable group, that faces life-threatening infection every day. Patients with chronic hemodialysis catheters face the risk of catheter infection, hospitalization and even premature death from sepsis and its complications.
On this slide, the National Health
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |